GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types

被引：18

作者：

Sievers, Philipp ^{[1
,2
]}

Stichel, Damian ^{[1
,2
]}

Sill, Martin ^{[3
,4
]}

Schrimpf, Daniel ^{[1
,2
]}

Sturm, Dominik ^{[3
,5
,25
]}

Selt, Florian ^{[3
,5
,6
]}

Ecker, Jonas ^{[3
,5
,6
]}

Kazdal, Daniel ^{[7
]}

Miele, Evelina ^{[8
]}

Kranendonk, Marieatte E. G. ^{[9
]}

Tops, Bastiaan B. J. ^{[9
]}

Kohlhof-Meinecke, Patricia ^{[10
]}

Beschorner, Rudi ^{[11
]}

Kramm, Christof M. ^{[12
]}

Hasselblatt, Martin ^{[13
]}

Reifenberger, Guido ^{[14
,15
]}

Capper, David ^{[16
,17
,18
,19
]}

Wesseling, Pieter ^{[9
,20
,21
]}

Stenzinger, Albrecht ^{[7
]}

Milde, Till ^{[3
,5
,6
]}

Korshunov, Andrey ^{[1
,2
,3
]}

Witt, Olaf ^{[3
,5
,6
]}

Pfister, Stefan M. ^{[3
,4
,5
]}

Wick, Wolfgang ^{[22
,23
,24
]}

von Deimling, Andreas ^{[1
,2
]}

Jones, David T. W. ^{[3
,25
]}

Sahm, Felix ^{[1
,2
,3
]}

机构：

[1] Univ Hosp Heidelberg, Inst Pathol, Dept Neuropathol, Heidelberg, Germany

[2] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany

[3] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[4] German Canc Res Ctr, German Canc Consortium DKTK, Div Pediat Neurooncol, Heidelberg, Germany

[5] Univ Hosp Heidelberg, Dept Pediat Oncol Hematol Immunol & Pulmonol, Heidelberg, Germany

[6] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Pediat Oncol, Heidelberg, Germany

[7] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany

[8] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Oncohematol & Cell & Gene Therapy, Rome, Italy

[9] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands

[10] Klinikum Stuttgart, Dept Pathol, Stuttgart, Germany

[11] Univ Tubingen, Dept Neuropathol, Tubingen, Germany

[12] Univ Med Ctr Gottingen, Div Pediat Hematol & Oncol, Gottingen, Germany

[13] Univ Hosp Munster, Inst Neuropathol, Munster, Germany

[14] Heinrich Heine Univ, Inst Neuropathol, Dusseldorf, Germany

[15] German Canc Consortium DKTK, Partner Site Essen Dusseldorf, Dusseldorf, Germany

[16] Charite Univ Med Berlin, Berlin, Germany

[17] Free Univ Berlin, Berlin, Germany

[18] Humboldt Univ, Inst Neuropathol, Berlin, Germany

[19] German Canc Res Ctr, German Canc Consortium DKTK, Partner Site Berlin, Heidelberg, Germany

[20] Amsterdam Univ Med Ctr, Locat VUmc, Dept Pathol, Amsterdam, Netherlands

[21] Brain Tumor Ctr Amsterdam, Amsterdam, Netherlands

[22] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neurooncol, Heidelberg, Germany

[23] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Dept Neurol, Heidelberg, Germany

[24] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Neurooncol Program, Heidelberg, Germany

[25] German Canc Res Ctr, Pediat Glioma Res Grp, Heidelberg, Germany

来源：

ACTA NEUROPATHOLOGICA | 2021年 / 142卷 / 06期

关键词：

CRIZOTINIB;

D O I：

10.1007/s00401-021-02369-1

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

下载

页码：1065 / 1069

页数：5

共 50 条

[21] ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1
Fielder, Timothy
Butler, Jordan
Tierney, Geraldine
Holmes, Mikaela
Lam, Ki Yuk
Satgunaseelan, Laveniya
Colebatch, Andrew J.
Mahar, Annabelle
Gupta, Ruta
O'Toole, Sandra
Cooper, Wendy A.
PATHOLOGY, 2022, 54 (04) : 399 - 403
[22] Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization
Huang, Richard S. P.
Smith, Derek
Le, Catherine H.
Liu, Wen-Wei
Ordinario, Ellen
Manohar, Chitra
Lee, Michael
Rajamani, Jaya
Truong, Huan
Li, Jing
Choi, Cindy
Li, Jingchuan
Pati, Amrita
Bubendorf, Lukas
Buettner, Reinhard
Kerr, Keith M.
Lopez-Rios, Fernando
Marchetti, Antonio
Marondel, Ivonne
Nicholson, Andrew G.
Oz, Aysim Buge
Pauwels, Patrick
Penault-Llorca, Frederique
Rossi, Giulio
Thunnissen, Erik
Newell, Amy Hanlon
Pate, Greg
Menzl, Ina
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (06) : 735 - 741
[23] Lung Adenocarcinomas with ROS1 Rearrangement show Diffuse Strong ROS1 Immunohistochemical Staining
Fielder, T.
Butler, J.
Tierney, G.
Holmes, M.
Lam, K. Y.
Satgunaseelan, L.
Colebatch, A.
Mahar, A.
Gupta, R.
O'Toole, S.
Cooper, W.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S968 - S968
[24] ROS1 Immunohistochemistry as a Screen for ROS1 Rearrangements in Lung Adenocarcinoma: Application in Clinical Practice
Pal, Prodipto
Hammerman, Peter
Kwiatkowski, David J.
Johnson, Bruce E.
Sholl, Lynette M.
LABORATORY INVESTIGATION, 2016, 96 : 478A - 478A
[25] ROS1 Immunohistochemistry as a Screen for ROS1 Rearrangements in Lung Adenocarcinoma: Application in Clinical Practice
Pal, Prodipto
Hammerman, Peter
Kwiatkowski, David J.
Johnson, Bruce E.
Sholl, Lynette M.
MODERN PATHOLOGY, 2016, 29 : 478A - 478A
[26] VCL::ROS1: A Novel ROS1 Oncogenic Fusion Detected on Next Generation Sequencing
Mehta, Anurag
Diwan, Himanshi
Nathany, Shrinidhi
Batra, Ullas
Gupta, Manoj
Panigrahi, Manoj Kumar
Kumar, Dushyant
Mattoo, Sakshi
Singh, Aayushi
CLINICAL PATHOLOGY, 2024, 17
[27] ROS1 FUSIONS DIAGNOSED BY BREAK-APART FISH IN NSCLC
Sheren, Jamie
Bennati, Chiara
Anh Le
Lu, Xian
Berge, Eamon
Aisner, Dara
Baron, Anna
Crino, Lucio
Camidge, D. Ross
Doebele, Robert C.
Varella-Garcia, Marileila
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S321 - S321
[28] The analysis of ROS1 fusions characteristics in Chinese solid tumor patients
Lin, Y.
Zhao, Y.
Guo, D.
Lu, G.
Deng, W.
Bu, F.
Ding, R.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S577 - S577
[29] A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
Viola, Patrizia
Maurya, Manisha
Croud, James
Gazdova, Jana
Suleman, Nadia
Lim, Eric
Newsom-Davis, Tom
Plowman, Nick
Rice, Alexandra
Montero, M. Angeles
de Castro, David Gonzalez
Popat, Sanjay
Nicholson, Andrew G.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 1029 - 1039
[30] Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins
Rihawi, Karim
Cinausero, Marika
Fiorentino, Michelangelo
Salvagni, Stefania
Brocchi, Stefano
Ardizzoni, Andrea
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (03) : E41 - E43

← 1 2 3 4 5 →